Literature DB >> 10556503

Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.

A E Fleckenstein1, H M Haughey, R R Metzger, J M Kokoshka, E L Riddle, J E Hanson, J W Gibb, G R Hanson.   

Abstract

High-dose administrations of amphetamine, methamphetamine, cathinone, methcathinone or methylenedioxymethamphetamine rapidly decrease dopamine and serotonin transporter function in vivo, as assessed in striatal synaptosomes obtained from drug-treated rats. In contrast, high-dose injections of fenfluramine, cocaine or methylphenidate had little or no effect on the activity of these transporters. Interestingly, the capacity of these agents to directly alter dopamine and serotonin uptake, as assessed in vitro by direct application to rat striatal synaptosomes, did not predict their potential to modulate transporter activity following in vivo administration. These findings demonstrate heretofore-unreported differences in the effects of these agents on monoamine transporter function, and a distinction between drug effects after direct application in vitro vs. administration in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556503     DOI: 10.1016/s0014-2999(99)00588-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  29 in total

1.  Regulation of genes involved in dopamine transporter modulation by acute cocaine in rat striatum.

Authors:  Cindie Courtin; Dominique Crete; Corinne Canestrelli; Florence Noble; Cynthia Marie-Claire
Journal:  Neurosci Lett       Date:  2006-02-03       Impact factor: 3.046

2.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

3.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 4.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

5.  Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.

Authors:  Eric S Ramsson; Daniel P Covey; David P Daberkow; Melissa T Litherland; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2011-05-03       Impact factor: 5.372

6.  Using In Vivo Electrochemistry to Study the Physiological Effects of Cocaine and Other Stimulants on the Drosophila melanogaster Dopamine Transporter.

Authors:  Monique A Makos; Kyung-An Han; Michael L Heien; Andrew G Ewing
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

7.  The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men.

Authors:  Elsmarieke van de Giessen; Jan Booij
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-23       Impact factor: 9.236

8.  Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy.

Authors:  Cheryse A Furman; Rong Chen; Bipasha Guptaroy; Minjia Zhang; Ronald W Holz; Margaret Gnegy
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

9.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

10.  Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia.

Authors:  Gina Rae Kruse; Russell Barbour; Robert Heimer; Alla V Shaboltas; Olga V Toussova; Irving F Hoffman; Andrei P Kozlov
Journal:  Harm Reduct J       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.